Programmed cell death (PCD), a term used to describe naturally occurring cell death, plays an important role in the generation and maintenance of the proper numbers and types of cells in animals. The elimination of superfluous cells in a way that is harmless to animals is essential for the developing nervous system and immune system. In many circumstances, cells undergoing PCD display a morphology of apoptosis, with the characteristic chromatin condensation while the membrane remains intact and intracellular organelles are preserved (1) . Fragmentation of chromosomal DNA to the size of oligonucleosomes is frequently observed (for review, see refs. [2] [3] [4] ).
The precise mechanism of PCD and the regulation of the process remain largely unclear (5, 6) . Genetic analyses in the nematode Caenorhabditis elegans have identified two genes, ced-3 and ced4, that are essential for PCD (7, 8) . Another gene, ced-9, seems to function normally as a suppressor of apoptosis (9) . In mammals, it was suggested that the protooncogene c-myc is directly involved in initiating apoptosis in fibroblasts and possibly also in other cells (10) . On the other hand, bcl-2, another protooncogene whose product is located in the inner membrane of mitochondria, was shown to be able to suppress apoptosis upon deregulated expression in certain hematopoietic cells (11) (12) (13) (14) (15) . However, it is not known how those gene products participate in apoptosis or its suppression.
Our studies focus on apoptosis of the interleukin 2 (IL-2)-dependent cell line CTLL2 induced by IL-2 deprivation (16) . We found that IL-2-induced gene transcription is required to suppress cell death in CTLL2 cells and tested the possibility that IL-2 induces bcl-2 transcription, which in turn may protect CTLL2 cells from apoptosis. Here we report that transcription of the cellular bcl-2 gene is down-regulated by IL-2 deprivation and up-regulated by IL-2 addition. Deregulated expression of bcl-2 prolongs the survival of CTLL2 cells in the absence of IL-2.
MATERIALS AND METHODS
Cell Culture. The cytotoxic T-cell line CTLL2 (17) was cultured in Iscove's modified Dulbecco's medium supplemented with 5% (vol/vol) fetal bovine serum, 50 ,uM 2-mercaptoethanol, and IL-2 (100 units/ml) supplied in a 1% supernatant of recombinant mouse IL-2, produced by the myeloma X63Ag8-653.mIL-2 (18 h (data not shown). In the absence of IL-2, DNA breakdown started abruptly 8 h after IL-2 was removed and proceeded to total degradation in all labeled cells at a rapid rate within the next 3.5 h. When IL-2 was added to pulse-labeled cells (arrow in Fig. la ) 8 h after IL-2 deprivation, the incipient DNA degradation that had just started continued for -2 h and then stopped. This IL-2 rescue was abolished if actinomycin D, a transcriptional blocker, was added to the culture 1 h before the addition of IL-2. Both actinomycin D and a-amanitin, a specific RNA polymerase II blocker (Fig. lb) , abolished the IL-2-induced protection against apoptosis. The a-amanitin dose required for the blocking effect correlates with the optimal dose for transcriptional inhibition of the polymerase (22) . Contrary to its effect on glucocorticoid-treated thymocytes (6), actinomycin D did not protect CTLL2 cells from death in the absence of IL-2. It caused DNA fragmentation even in the presence of IL-2, as typical DNA ladders were found (Fig. lc) . Cycloheximide blocked DNA degradation induced by the absence of IL-2 or the inhibition of IL-2-dependent transcription (Fig. ld) . These data suggest that IL-2 induces the transcription of a protecting factor that is required to counteract apoptosis. Thus, the growth factor may actively suppress the initiation of cell death. CTLL2 cell death apparently requires translation of a preexisting longlived mRNA.
Overexpression of bcl-2 cDNA Prolongs Survival of IL-2-Dependent CTLL2 cells. Deregulated expression of the protooncogene bcl-2 protects certain hematopoietic cells from apoptosis upon growth-factor deprivation (11) . Such cells include IL-3 and colony-stimulating-factor-dependent cell lines. We tested the possibility that bcl-2 may also protect IL-2-dependent CTLL2 cells. CTLL2 cells were transfected with an episomal multicopy plasmid (18) , pBMGNeo, conferring neomycin resistance and containing the coding region of the murine bcl-2 cDNA expressed under the murine metallothionein promoter. Transfectants were selected by G418. The cells were additionally selected by a brief period (Fig. 2) or untransfected CTLL2 cells (data not shown). Upon IL-2 deprivation, 50%o of the transfected CTLL2/neo cells died by 24 h, as measured by trypan blue uptake, and no viable cells were detectable by 48 h. In bcl-2-transfected CTLL2/bcl-2 cells, however, cell death was significantly delayed; 50% cell death was observed only after -96 h (Fig. 2a) . CTLL2/bcl-2 cells continued to proliferate slowly for 2 days after IL-2 deprivation (Fig. 2b) . The cells then started to die slowly even when incubated in fresh medium, ruling out nutrient depletion as the cause of death. DNA degradation was observed in the dying cells (data not shown). Cell cycle analysis of IL-2-deprived bcl-2-transfected CTLL2 cells showed that the cells were arrested in the Go/Gl and the G2/M phases, as determined by propidium iodide staining (Fig. 3) . Prolonged starvation resulted in DNA fragmentation, with the appearance of cells containing less DNA than diploid cells. If IL-2 was added back to the culture 72 h after withdrawal, CTLL2/bcl-2 cells resumed growth 6 h later (data not shown, but see Fig. 4 ). Thus deregulated expression of bcl-2 prolongs the survival ofCTLL2 cells deprived ofIL-2.
Cellular bcl-2 Transcription Is Regulated by IL-2. Since IL-2-induced transcription is required to suppress apoptosis of CTLL2 cells and the overexpression of bcl-2 protects CTLL2 cells from death, we asked whether transcription of bcl-2 is IL-2-dependent and whether IL-2 deprivation turns off the cellular bcl-2 gene. Cytoplasmic RNA extracted from CTLL2 cells was analyzed for bcl-2 expression on a Northern blot. In control transfected cells (CTLL2/neo), IL-2 withdrawal led to a rapid decline of cellular bcl-2 expression within 4 h and the subsequent apoptosis of all cells (Fig. 4a) .
bcl-2 transfected CTLL2 (CTLL2/bcl-2) cells allowed us to test the induction of cellular bcl-2 transcription by IL-2 because these cells did not die immediately when deprived of IL-2. Endogenous bcl-2 transcripts are 7.5 kb and 2.4 kb and are, therefore, distinguishable from the 1.5-kb transfected bcl-2 transcript. The bcl-2 probe also cross-hybridizes with the 28S RNA (23). Cytoplasmic RNA from CTLL2/bcl-2 cells was analyzed for expression of bcl-2 (Fig. 5a ), c-myc (Fig. Sb) , and, as control, f-actin (Fig. Sc) Probes: a, murine bcl-2; b, murine 3-actin. decreased rapidly to low levels within 8 h of IL-2 deprivation and then decreased slowly until 48 h after deprivation. In contrast, deregulated bcl-2 expressed by the plasmid vector remained constantly high during this time (bcl-2, 1.5 kb) except at 72 h after IL-2 removal, when 50% of the cells were dead. By 72 h of IL-2 deprivation, no endogenous bcl-2 was detected even after 7 days of autoradiography. Upon addition of IL-2, a 2.4-kb bcl-2 mRNA (23) was detected within 2 h. Eight hours after IL-2 addition, the higher molecular mass forms of bcl-2 are induced to the level of full recovery.
Similar patterns of loss of bcl-2 expression were observed in several transfected CTLL2 clones. The primary difference between individual clones was the length of survival without IL-2; the higher the transfected bcl-2 mRNA level, the longer the average survival without IL-2 (data not shown).
The filter shown in Fig. Sa was stripped and hybridized again with a radioactive c-myc probe. Expression of c-myc mRNA was down-regulated to a very low level by 24 h after IL-2 withdrawal (Fig. Sb) . Addition of IL-2 induced c-myc expression, which reached its maximum level at 8 h. The amount of the endogenous bcl-2 or c-myc RNA at each time point is shown in Fig. 6 . These data show that cellular bcl-2 transcription in CTLL2 cells depends on the continued presence of IL-2. It is down-regulated upon IL-2 deprivation and up-regulated by IL-2 stimulation.
DISCUSSION
Deprivation ofIL-2 from IL-2-dependent CTLL2 cells results in apoptotic cell death (16) . Does IL-2 withdrawal activate the expression of a suicide program of CTLL2 cells or, conversely, remove the suppression of a preexisting suicide program in CTLL2 cells? Our studies support the hypothesis that the growth factor induces, via transcription, a protecting factor that suppresses the initiation or the completion of the suicide program.
Apoptosis in both mature T cells, such as CTLL2 cells deprived of IL-2 (16), and immature T cells, such as thymocytes stimulated by glucocorticoid or anti-T-cell-receptor complex antibody (24) (25) (26) , requires protein synthesis, implying the activation of a "suicide gene" product. This suicide gene product could be an endonuclease that is responsible for the internucleosomal cleavage observed or its activator (27, 28) . In contrast to apoptosis of thymocytes (26, 28) , we showed that cell death in CTLL2 cells did not require transcription. In fact, inhibition of transcription induced apoptosis of CTLL2 cells even in the presence of IL-2. In addition, the rescue effect of IL-2 was also abolished by the presence of transcriptional blockers (Fig. 1) . Neither the absence of the IL-2 signal nor the absence of IL-2-inducible transcription results in cell death if, in addition, protein synthesis was also inhibited. Therefore, apoptosis of CTLL2 cells probably results from the translation of a long-lived "suicide transcript," which is otherwise under a constant suppression by the IL-2-induced protecting factors. CTLL2 cells, as terminally differentiated cells, are primed to die and their survival depends on the continued presence of external signals.
Could bcl-2 be the protecting factor induced by IL-2 in CTLL2 cells? Since deregulated expression of the protooncogene bcl-2 suppresses apoptosis in a number of hematopoietic cell lines, we asked whether overexpression of bcl-2 suppressed cell death in CTLL2 cells. We also wished to know whether the transcription of cellular bcl-2 is induced by IL-2 and whether IL-2 withdrawal resulted in a downregulation of bcl-2 expression. This was achieved by transfecting CTLL2 cells with an episomal plasmid containing the murine bcl-2 full-length coding region under the metallothionein promoter.
Our studies showed prolonged survival of bcl-2-transfected CTLL2 cells during IL-2 deprivation in comparison to untransfected cells or cells transfected with the vector alone (Fig. 2) . Cells expressing higher levels of the transfected bcl-2 gene appeared to survive longer. CTLL2 cells transfected with a retroviral vector containing bcl-2 cDNA under simian virus 40 promoter did not survive longer when deprived of IL-2 (11). The difference may be explained by the high copy number of the episomal plasmid we used and the correspond- Northern blot analysis showed that the transcription of cellular bcl-2 decreased quickly after the removal of IL-2 from CTLL2/neo cells (Fig. 4a) . The availability of bcl-2-transfected CTLL2 cells enabled us to study the induction of cellular bcl-2 transcription by IL-2 since deregulated bcl-2 allowed cell survival in the absence ofIL-2. As shown in Figs. Sa and 6, endogenous bcl-2 transcription was induced by IL-2 to a high level in a short time (8 h). Intriguingly, the 2.4-kb transcript, which was derived from the first exon and the immediately following poly(A) signal (23), appeared earlier.
The bcl-2 signal detected at 5.0 kb (28S) was reported to be either a cross-hybridization with the 28S rRNA or a transcript of 5.0 kb (23) . We confirmed that the signal is a crosshybridization with the 28S rRNA, as it was not detected in poly(A)-selected RNA (data not shown).
Thus, bcl-2 appears to be an apoptosis-suppressing gene whose transcription in CTLL2 cells is dependent on IL-2. It remains to be determined whether this is the normal function of bcl-2 in these cells and whether bcl-2 is the sole suppressor induced by IL-2. Up-regulation of bcl-2 expression was also observed in chronic lymphocytic leukemic B cells treated with IL-4 (29) . IL-4 treatment prevents both proliferation and apoptosis of those cells.
Deregulated expression of the protooncogene myc was reported (10) to be able to induce apoptosis in fibroblasts blocked in proliferation. A model was proposed in which myc, probably via its transcriptional modulation activity, drives two coupled functions: proliferation and PCD. We tested the IL-2 regulation of c-myc transcription in CTLL2/ bcl-2 cells by IL-2 ( Fig. 5b) and found that IL-2 withdrawal was accompanied by rapid decline in c-myc mRNA expression. Addition of IL-2 resulted in an elevated level of c-myc transcription. The IL-2 modulation of c-myc transcription was parallel to that of bcl-2 (Fig. 6 ). Although it is still possible that c-myc activates the transcription of the postulated long-lived suicide message, which was suppressed by the transfected bcl-2 gene, this observation does not address the mechanism of the interaction between myc and bcl-2. It is also noteworthy that protection from apoptosis in the absence of IL-2 results in cessation of proliferation and cell cycle arrest in both Go/Gl and G2/M phases. Our studies thus point to a highly integrated regulation by IL-2 of the cell cycle, apoptosis, and regulation of myc and bcl-2 mRNAs. However, the precise sequence of events leading to DNA replication or DNA degradation requires further analysis.
